Genesis Healthcare, Inc.
GEN
GEN was delisted on the 25th of March, 2021.
77 hedge funds and large institutions have $76.1M invested in Genesis Healthcare, Inc. in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 34 increasing their positions, 15 reducing their positions, and 3 closing their positions.
400% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 3
127% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 15
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
82% more capital invested
Capital invested by funds: $41.8M → $76.1M (+$34.3M)
18% more funds holding
Funds holding: 65 → 77 (+12)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CA
Cornerstone Advisory
Hunt Valley,
Maryland
|
+$1.04M |
| 2 |
Renaissance Technologies
New York
|
+$660K |
| 3 |
Wells Fargo
San Francisco,
California
|
+$640K |
| 4 |
FWC
First Washington Corp
Seattle,
Washington
|
+$616K |
| 5 |
JP Morgan Chase
New York
|
+$563K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$199K |
| 2 |
SIM
Spark Investment Management
New York
|
-$163K |
| 3 |
Goldman Sachs
New York
|
-$140K |
| 4 |
RhumbLine Advisers
Boston,
Massachusetts
|
-$56.7K |
| 5 |
FM
Forward Management
San Francisco,
California
|
-$49.4K |
GEN Hedge Fund Activity: Q4 2016 in Review
77 of the 4,008 institutional investors tracked by Wall St. Rank reported a position in Genesis Healthcare, Inc. (GEN) for Q4 2016, worth a combined $76.1M — up 82% from $41.8M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new GEN positions and 3 closed out — a net gain of 12 holders — while 34 added to existing stakes and 15 trimmed.
The largest buyer was Cornerstone Advisory, opening a new position worth an estimated $1.04M. The largest seller was Citadel Advisors, cutting an estimated $199K.
- 77 institutional investors held Genesis Healthcare, Inc. (GEN) as of Q4 2016, up from 65 in Q3 2016.
- Funds reported $76.1M of Genesis Healthcare, Inc. stock for Q4 2016, up 82% quarter-over-quarter.
- 15 funds opened new Genesis Healthcare, Inc. positions in Q4 2016 and 3 closed out, a net change of +12 holders.
- The largest Genesis Healthcare, Inc. buyer in Q4 2016 was Cornerstone Advisory, an estimated $1.04M added.
- The largest Genesis Healthcare, Inc. seller in Q4 2016 was Citadel Advisors, an estimated $199K sold.
Based on aggregated 13F filings for Q4 2016.